Justin Garner

2.8k total citations · 1 hit paper
35 papers, 335 citations indexed

About

Justin Garner is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services. According to data from OpenAlex, Justin Garner has authored 35 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 4 papers in Emergency Medical Services. Recurrent topics in Justin Garner's work include Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers), Respiratory Support and Mechanisms (13 papers) and Tracheal and airway disorders (9 papers). Justin Garner is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers), Respiratory Support and Mechanisms (13 papers) and Tracheal and airway disorders (9 papers). Justin Garner collaborates with scholars based in United Kingdom, Netherlands and United States. Justin Garner's co-authors include Pallav L. Shah, Dirk‐Jan Slebos, Samuel V. Kemp, Jorine E. Hartman, Christopher M. Orton, Philip L. Molyneaux, Anand Devaraj, Richard Hewitt, Robert J. Snelgrove and Sujal R. Desai and has published in prestigious journals such as Immunity, American Journal of Respiratory and Critical Care Medicine and Journal of Applied Physiology.

In The Last Decade

Justin Garner

27 papers receiving 330 citations

Hit Papers

Immuno-proteomic profiling reveals aberrant immune cell r... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justin Garner United Kingdom 10 220 64 61 57 50 35 335
James Tonkin United Kingdom 5 123 0.6× 40 0.6× 98 1.6× 70 1.2× 20 0.4× 13 240
S. Yu. Chikina Russia 8 155 0.7× 37 0.6× 67 1.1× 34 0.6× 48 1.0× 38 277
Claire McGroder United States 6 96 0.4× 31 0.5× 82 1.3× 75 1.3× 24 0.5× 12 218
Jack Boyd United States 6 152 0.7× 17 0.3× 37 0.6× 45 0.8× 76 1.5× 12 353
Christoph Ruwwe‐Glösenkamp Germany 9 139 0.6× 22 0.3× 55 0.9× 30 0.5× 14 0.3× 14 225
Bavithra Vijayakumar United Kingdom 6 105 0.5× 15 0.2× 158 2.6× 123 2.2× 31 0.6× 17 284
A.J. Gangemi United States 7 131 0.6× 41 0.6× 22 0.4× 22 0.4× 27 0.5× 24 193
Nikhil Huprikar United States 8 76 0.3× 29 0.5× 63 1.0× 44 0.8× 17 0.3× 19 182
Gioia Cappelletti Italy 9 181 0.8× 11 0.2× 66 1.1× 55 1.0× 55 1.1× 21 357
Cuilian Guo China 9 61 0.3× 106 1.7× 38 0.6× 90 1.6× 41 0.8× 21 337

Countries citing papers authored by Justin Garner

Since Specialization
Citations

This map shows the geographic impact of Justin Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Garner more than expected).

Fields of papers citing papers by Justin Garner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Garner. The network helps show where Justin Garner may publish in the future.

Co-authorship network of co-authors of Justin Garner

This figure shows the co-authorship network connecting the top 25 collaborators of Justin Garner. A scholar is included among the top collaborators of Justin Garner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin Garner. Justin Garner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tana, Anand, Arschang Valipour, Alvin Ing, et al.. (2025). Airway Scaffolds for Emphysema-related Hyperinflation: Six-Month Results from the BREATHE Trial. American Journal of Respiratory and Critical Care Medicine. 211(7). 1175–1184. 1 indexed citations
3.
Garner, Justin, et al.. (2025). Cross-Platform Analysis of Mammography Narratives: A Comparative Study on Social Media Engagement. Journal of patient-centered research and reviews. 12(1). 9–20. 1 indexed citations
4.
Orton, Christopher M., Justin Garner, Anand Tana, et al.. (2024). Feasibility of continuous bronchoscopy during exercise in the assessment of large airway movement in healthy subjects. Journal of Applied Physiology. 136(6). 1429–1439. 2 indexed citations
5.
Thiru, S, Yu Gao, Amy Zhou, et al.. (2024). Gender disparities in authorship: A fifteen-year bibliometric analysis of interventional radiology journals. Current Problems in Diagnostic Radiology. 54(1). 87–91.
6.
Garner, Justin, Christopher M. Orton, Andrew G. Nicholson, et al.. (2024). Low bleeding rates following transbronchial lung cryobiopsy in unclassifiable interstitial lung disease. Respirology. 29(6). 489–496.
7.
Garner, Justin, Christopher M. Orton, Andrew G. Nicholson, et al.. (2024). Low bleeding rates following transbronchial lung cryobiopsy in unclassifiable interstitial lung disease. PA778–PA778.
8.
Pison, Christophe, Pallav L. Shah, Dirk‐Jan Slebos, et al.. (2021). Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes. Respiratory Research. 22(1). 62–62. 12 indexed citations
9.
Pison, Christophe, Pallav L. Shah, Dirk‐Jan Slebos, et al.. (2021). Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes. Respiratory Research. 22(1). 83–83.
10.
Hartman, Jorine E., Justin Garner, Pallav L. Shah, & Dirk‐Jan Slebos. (2021). New bronchoscopic treatment modalities for patients with chronic bronchitis. European Respiratory Review. 30(159). 200281–200281. 20 indexed citations
11.
Garner, Justin, Martyn F. Biddiscombe, Sally Meah, et al.. (2021). Endobronchial valve lung volume reduction and small airways function. PA1832–PA1832.
12.
Dransfield, Mark T., Justin Garner, Surya P. Bhatt, et al.. (2020). Effect of Zephyr Endobronchial Valves on Dyspnea, Activity Levels, and Quality of Life at One Year. Results from a Randomized Clinical Trial. Annals of the American Thoracic Society. 17(7). 829–838. 15 indexed citations
13.
Garner, Justin, Samuel V. Kemp, Cielito Caneja, et al.. (2020). 5-Year Survival after Endobronchial Coil Implantation: Secondary Analysis of the First Randomised Controlled Trial, RESET. Respiration. 99(2). 154–162. 12 indexed citations
14.
Garner, Justin, Tawimas Shaipanich, Jorine E. Hartman, et al.. (2020). A prospective safety and feasibility study of metered cryospray for patients with chronic bronchitis in COPD. European Respiratory Journal. 56(6). 2000556–2000556. 15 indexed citations
15.
Garner, Justin, et al.. (2019). Evaluation of a re-useable bronchoscopy biosimulator with ventilated lungs. ERJ Open Research. 5(2). 35–2019. 8 indexed citations
16.
Shen, Mali, William McNulty, Justin Garner, et al.. (2019). Quantitative Evaluation of Lobar Pulmonary Function of Emphysema Patients with Endobronchial Coils. Respiration. 98(1). 70–81. 8 indexed citations
17.
Valipour, Arschang, Pallav L. Shah, Christophe Pison, et al.. (2019). Safety and Dose Study of Targeted Lung Denervation in Moderate/Severe COPD Patients. Respiration. 98(4). 329–339. 27 indexed citations
18.
Wechalekar, Kshama, et al.. (2018). Pre-surgical Evaluation of Lung Function. Seminars in Nuclear Medicine. 49(1). 22–30. 2 indexed citations
19.
Garner, Justin, Samuel V. Kemp, Tudor Toma, et al.. (2016). Survival after Endobronchial Valve Placement for Emphysema: A 10-Year Follow-up Study. American Journal of Respiratory and Critical Care Medicine. 194(4). 519–521. 37 indexed citations
20.
Garner, Justin, Peter M. George, & Elisabetta Renzoni. (2015). Cough in interstitial lung disease. Pulmonary Pharmacology & Therapeutics. 35. 122–128. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026